Cargando…
A CONTROL CLINICIAL TRIAL OF A NEW ANXIOLYTIC ‘CLOBAZAM’
Clobazam as a twice-a-day dosage (10 mg-20 mg) regimen and Diazepam in a thrice-a-day schedule (5 mg-5 mg-5 mg) were both effective in controlling moderate to severe anxiety neurosis. 83 patients were studied in a controlled, randomised, double-blind trial. Patients received active drug for the firs...
Autores principales: | Singh, Gurmeet, Kumar, Vijay, Kapur, Rupinder |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
1984
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012220/ https://www.ncbi.nlm.nih.gov/pubmed/21965973 |
Ejemplares similares
-
Acta Instituti Clinici Universitatis Vilnensis
Publicado: (1810) -
Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials
por: Gunning, Boudewijn, et al.
Publicado: (2020) -
Il versamento pleurico: aspetti eziologici, diagnostici e clinici
por: Zuccatosta, Lina
Publicado: (2007) -
ANXIETY AND DEPRESSIVE NEUROSIS - THEIR RESPONSE TO ANXIOLYTIC AND ANTIDEPRESSANT TREATMENT
por: Singh, Gurmeet, et al.
Publicado: (1987) -
Cannabidiol efficacy independent of clobazam: Meta‐analysis of four randomized controlled trials
por: Devinsky, Orrin, et al.
Publicado: (2020)